QualityStocksNewsBreaks Archives - Page 9 of 1407

ThursdayAug 07, 2025 9:59 am

QualityStocksNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Announces $2.4 Million Warrant Inducement Transaction

Wearable Devices (NASDAQ: WLDS, WLDSW), an award-winning AI-based gesture control technology company, has entered a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 1,661,000 ordinary shares at $1.45 per share, generating approximately $2.4 million in gross proceeds. In exchange, the investor will receive 3,322,000 new unregistered warrants in a private placement, exercisable at $1.71 per share upon shareholder approval. Net proceeds will be used for working capital and general corporate purposes. The closing is expected on or about August 7, 2025, subject to customary conditions. To view the full press…

ThursdayAug 07, 2025 9:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Multilingual Podcast to Raise Awareness of Breast Imaging Innovation

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging technologies for breast cancer detection, has launched a multilingual podcast series titled Beyond the Mammogram: Rethinking the Future of Breast Imaging. Available in seven languages, the series aims to inform global audiences about limitations in current imaging tools and the need for more accurate technologies like Izotropic’s IzoView Breast CT system. The podcast repurposes public data into educational content for patients, professionals, and stakeholders as the Company moves toward regulatory approval. To view the full press release, visit https://ibn.fm/FDgr9 About Izotropic More information about Izotropic Corporation can…

ThursdayAug 07, 2025 9:00 am

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment options. Japan’s high incidence of never-smoker NSCLC makes it a strategic region for the trial. LP-300 is being tested alongside standard chemotherapy agents in patients who have relapsed after tyrosine kinase inhibitor therapy. Lantern's AI-driven approach may help identify and accelerate development of therapies in underserved cancer markets. Additional trial data from Taiwan and the U.S. is expected later in Q3 2025. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has completed targeted patient…

WednesdayAug 06, 2025 12:45 pm

QualityStocksNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Launches AI-Powered Touchless Neural Control Project for Military Use

Wearable Devices (NASDAQ: WLDS, WLDSW), a developer of AI-powered touchless sensing wearables, announced the launch of a military-focused project to advance human-machine interface (HMI) technology. The initiative aims to deliver a neural control system enabling soldiers to operate tactical systems through intuitive gestures without physical contact. Powered by the company’s proprietary neural interface and AI-driven sensors, the technology is designed to enhance battlefield efficiency and safety. This move reinforces Wearable Devices’ leadership in neural input innovation and expands its reach into the defense sector. To view the full press release, visit https://ibn.fm/8EJBq About Wearable Devices Ltd. Wearable Devices Ltd. (NASDAQ:…

WednesdayAug 06, 2025 12:10 pm

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial

Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New Drug (“IND”) application to initiate a Phase Ib/2a clinical trial of STAR-001 (LP-184) in combination with spironolactone for patients with glioblastoma multiforme (“GBM”) at first progression. The study will evaluate safety, tolerability and preliminary efficacy in recurrent GBM, a highly aggressive brain cancer with limited treatment options. STAR-001 is a brain-penetrant DNA-damaging agent designed to exploit DNA repair deficiencies through synthetic lethality, and its effect is enhanced by spironolactone, which induces NER deficiency in tumor cells. The therapy has received…

WednesdayAug 06, 2025 10:00 am

QualityStocksNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Offers $7,500 Price Cut on Mullen ONE and THREE EVs Ahead of Incentive Deadline

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced $7,500 in additional price adjustments for commercial customers purchasing existing inventory of its Mullen ONE and Mullen THREE EVs. With MSRPs now set at $27,000 and $61,000 respectively, the incentive—combined with a $7,500 Inflation Reduction Act credit for deliveries before September 30—positions both models as high-value options in the Class 1 and Class 3 commercial EV segments. Formerly known as Mullen Automotive, the company recently rebranded and will relabel the vehicles under Bollinger Motors beginning in the 2026 model year. The product lineup also includes the Bollinger B4 Class 4 truck,…

WednesdayAug 06, 2025 9:20 am

QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) to Report Q2 2025 Financial Results on August 14

NextPlat (NASDAQ: NXPL, NXPLW) a global provider of healthcare and technology solutions, will release its financial results for the quarter ended June 30, 2025, before market open on August 14. A conference call hosted by Interim CEO David Phipps and CFO Cecile Munnik will follow at 8:30 a.m. EDT to review the results and discuss recent developments. To view the full press release, visit: https://ibn.fm/BOgDL About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends to assist businesses…

WednesdayAug 06, 2025 9:00 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Expands High-Grade Tin and Silver Zones at Iska Iska Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) announced assay results from the first five holes of its restarted definition drilling program in the Santa Barbara starter pit area at the Iska Iska silver-tin polymetallic project in Bolivia. The drilling highlights include 0.89% Sn over 16.5m and 0.90% Sn over 13.5m in hole DSB-78, along with 401.65 g/t Ag over 3.0m in hole DSB-79. All five holes intersected significant tin and silver mineralization, mostly hosted in intrusion breccias, with visible cassiterite likely amenable to gravity separation. Results confirm lateral and downdip continuity, supporting further infill and step-out drilling to expand…

TuesdayAug 05, 2025 12:25 pm

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the…

TuesdayAug 05, 2025 9:40 am

QualityStocksNewsBreaks – InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) Welcomes Delek Group as Strategic Shareholder in Block Sale from Obsidian Energy

InPlay Oil (TSX: IPO) (OTCQX: IPOOF) announced that Obsidian Energy Ltd. has entered a definitive agreement to sell its 9.1 million common shares in InPlay to Delek Group Ltd. The transaction, expected to close in the first half of August 2025, positions Delek as a strategic shareholder with rights to nominate two directors to InPlay’s board. InPlay CEO Doug Bartole highlighted Delek’s strong industry record, including major roles in Ithaca Energy and the Mediterranean’s largest natural gas field. The agreement includes registration and investor rights granting Delek participation and pre-emptive rights in future equity offerings. To view the full announcement,…

Site Search

Company Search

Category: QualityStocksNewsBreaks